Korsana Biosciences Inc. (KRSA:NASDAQ) closed at $31.03 on October 20, 2026, down 1.21% on the day. The stock trades 47.7% below its 52-week high of $59.36 and 331.6% above its 52-week low of $7.19. Over the past year, it gained 198.5%. Korsana Biosciences Inc. is part of the Health Care sector.
In 151 trading sessions since March 17, 2026, KRSA closed higher on 67 days (44%). Its best day was April 1, 2026 (+311.61%) and its worst was April 6, 2026 (-32.52%). The stock moved 10% or more in a single session 14 times. It opened at least 5% above the previous day's high 1 time.
Korsana Biosciences is committed to building best-in-class therapeutics with the goal of reducing the burden of neurodegenerative diseases for patients and caregivers. The Company's lead program, KRSA-028, is a next-generation shuttled antibody targeting amyloid beta for the treatment of Alzheimer's disease. KRSA-028 leverages Therapeutic Targeting (THETA), a novel CNS shuttle technology developed in partnership with Paragon Therapeutics and designed to enable dramatically higher drug concentrations in the brain and overcome the limitations of earlier shuttle technologies. In addition, Korsana is advancing a pipeline of innovative therapies for neurodegenerative diseases.
Find more stocks like KRSA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.